Other Parkinson's Disease treatments ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00537017 (ClinicalTrials.gov)	November 23, 2007	27/9/2007	Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)	A Phase 2, 36-Week, Open-Label, Uncontrolled Safety Follow-up Study Assessing SCH 420814 (Preladenan ...	Parkinson Disease;Neurodegenerative Diseases;Central Nervous System Diseases;Movement Disorders;Brai ...	Drug: Preladenant;Drug: L-dopa;Drug: Other Parkinson's Disease treatments	Merck Sharp & Dohme Corp.	NULL	Completed	30 Years	N/A	All	140	Phase 2	Argentina;Australia;Canada;Chile;Colombia;France;Guatemala;Hong Kong;Singapore;Spain;United States
2	NCT00406029 (ClinicalTrials.gov)	November 20, 2006	30/11/2006	Dyskinesia in Parkinson's Disease (Study P04501)	A Phase 2, 12-Week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and ...	Parkinson Disease;Movement Disorders;Central Nervous System Diseases;Neurodegenerative Diseases;Brai ...	Drug: Preladenant;Drug: Placebo;Drug: L-dopa;Drug: Other Parkinson's Disease treatments	Merck Sharp & Dohme Corp.	NULL	Completed	30 Years	N/A	All	253	Phase 2	Argentina;Australia;Canada;Chile;Colombia;France;Guatemala;Hong Kong;Italy;New Zealand;Peru;Singapor ...

First Previous1Next Last